Standard treatment plus trastuzumab for HER2+ gastric cancer
Dr Eric Van Cutsem - University Hospital Gasthuisberg, Belgium
Standard treatment plus trastuzumab for HER2+ gastric cancer ( Dr Eric Van Cutsem - University Hospital Gasthuisberg, Belgium )
3 Jul 2009
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash
Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
ASCO: Prophylactic creams and antibiotics reduce severe drug-related skin rash ( Dr. Edith Mitchell, Thomas Jefferson University, Philadelphia, Pennsylvania, USA )
22 Jun 2009
ASCO: Oxaliplatin does not improve outcomes for rectal cancer
Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy
ASCO: Oxaliplatin does not improve outcomes for rectal cancer ( Dr. Carlo Aschele - E.O. Ospedali Galliera, Italy )
18 Jun 2009
ASCO: Trial compares common adjuvant treatments for pancreatic cancer
Dr. John Neoptolemos - University of Liverpool, Liverpool, UK
ASCO: Trial compares common adjuvant treatments for pancreatic cancer ( Dr. John Neoptolemos - University of Liverpool, Liverpool, UK )
18 Jun 2009
ASCO: Surgery unnecessary for majority of patients with advanced colorectal canc...
Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO: Surgery unnecessary for majority of patients with advanced colorectal cancer ( Dr. Philip B. Paty - Memorial Sloan-Kettering Cancer Center, New York, USA )
18 Jun 2009
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-...
Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital,...
ASCO: Bevacizumab and standard adjuvant chemotherapy: no improvement in disease-free survival for early-stage colon cancer ( Dr Norman Wolmark - Chairman Dept of Human Oncology, Allegheny General Hospital, US )
17 Jun 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009
AACR 2009: Determinants of screening colonoscopy among african-american older ad...
Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School...
AACR 2009: Determinants of screening colonoscopy among african-american older adults ( Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA )
7 May 2009
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal canc...
Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Canc...
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )
1 May 2009
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeu...
Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )
30 Apr 2009